China Enhances Supervision Of Narcotic APIs With Tighter Supply Chain Controls
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's State FDA recently asked local FDAs to implement a new provision for drug precursor chemicals that will strengthen the supervision of narcotics to address the increasing problem of drug abuse across the country
You may also be interested in...
China Simplifies New Registration Provisions For Technology Transfers; Move Will Benefit MNCs
SHANGHAI - China's State FDA has released new provisions to simplify and standardize registration for drug technology transfers that will benefit multinational companies acquiring technologies in China
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).